NIT
LRMR icon

NumerixS Investment Technologies’s Larimar Therapeutics LRMR Stock Holding History

NumerixS Investment Technologies’s Portfolio LRMR Stock Details LRMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-2,728
Closed -$206K – 916
2015
Q4 		$206K Buy
+2,728
New +$438K 0.03% 691

Other funds holding LRMR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VM
VHCP Management New York $93M AUM 10.04% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

NumerixS Investment Technologies's LRMR Position: Q1 2016 in Review

NumerixS Investment Technologies sold out of Larimar Therapeutics (LRMR) in Q1 2016, closing a stake of 2,728 shares — an estimated $206K sold.

NumerixS Investment Technologies first reported a position in LRMR in Q4 2015 and held it in 1 quarter. The position peaked at $206K in Q4 2015. 80 funds tracked by Wall St. Rank hold LRMR as of Q1 2016.

  • NumerixS Investment Technologies reported no remaining Larimar Therapeutics position as of Q1 2016 after selling out during the quarter.
  • NumerixS Investment Technologies sold 2,728 Larimar Therapeutics shares in Q1 2016, an estimated $206K.
  • NumerixS Investment Technologies first reported a position in Larimar Therapeutics in Q4 2015 and held it in 1 quarter.
  • NumerixS Investment Technologies's Larimar Therapeutics position peaked at $206K in Q4 2015.
  • 80 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q1 2016.

Based on NumerixS Investment Technologies's 13F filing for Q1 2016, filed 5 May 2016.